ArticleEuropean journal of medical research2025
Integrated bioinformatics analysis unravels mitochondrial-immune crosstalk and infiltration dynamics in sepsis progression.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Identification of immune cell mitochondrial dysfunction characteristics and clinical predictive biomarkers in sepsis via multi-cohort machine learning and single-cell RNA sequencing.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026Article
- Mitochondrial Dysfunction in Circulating Blood Cells and Biological Aging: A Review of Mechanisms and Evidence.Biomolecules · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundSepsis is a critical illness, and mitochondrial dysfunction is associated with its progression. However, the classification of mitochondrial-related differentially expressed genes (MitoDEGs) in sepsis and the immune infiltration characteristics have not been thoroughly investigated. This study aimed to explore the relevant content.
methodsGene expression data were obtained from the Gene Expression Omnibus (GEO), while mitochondrial-related genes were sourced from the MitoCarta3.0 database. We applied Weighted Gene Co-expression Network Analysis (WGCNA) to identify Sepsis-related MitoDEGs (Se-MitoDEGs), and utilized unsupervised clustering analysis to categorize sepsis samples into distinct clusters. Machine learning algorithms identified hub Se-MitoDEGs, and a validation set and a nomogram for sepsis diagnosis were established. The CIBERSORT algorithm was employed to investigate immune infiltration characteristics in sepsis and their association with hub Se-MitoDEGs. The expression levels of relevant genes were evaluated in peripheral blood samples from septic patients and normal controls through quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). Associated transcription factors, miRNAs, and drugs were constructed into a diagram via NetworkAnalyst and Comparative Toxicogenomics Database (CTD).
results15 Se-MitoDEGs exhibited differential expression between septic and normal samples. Immune infiltration analysis demonstrated significant increases in neutrophils, activated mast cells, and M0 macrophages among septic patients compared to control subjects. We categorized sepsis samples into two clusters; most hub genes in cluster 2 (C2) were highly expressed, exhibiting low immune infiltration and immune score. Some differences were observed in the pathways between the two clusters. By utilizing machine learning techniques and the validation set, MSRB2, TSPO, and BLOC1S1 were identified, and a nomogram of the three genes exhibited a substantial area under the curve (AUC) of 0.886, and the AUC for the validation set was recorded at 0.866, highlighting the robustness of our predictive model. Survival analysis found that low expression of TSPO and high expression of MSRB2 in peripheral blood were negatively correlated with the 28-day survival rate of septic patients. qRT-PCR validation indicated that the expression levels of these three hub genes are consistent with our bioinformatics analysis results. Associated small molecules, including Estradiol, pirinixic acid, and Valproic acid, are potential therapeutic drugs for sepsis.
conclusionBy integrating bioinformatics with machine learning models, we identified three mitochondrial and immune-related biomarkers (MSRB2, TSPO, and BLOC1S1) with diagnostic value for sepsis. These biomarkers provide new insights into subtype stratification, immune infiltration characteristics, and targeted therapy in sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.